Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Providers of the data on the volume of sales of veterinary antimicrobials reported by EU member states and EEA countries to the European Medicines Agency for 2023 (10, 11)
| Data provider | Countries |
|---|---|
| Marketing Authorisation Holders | Austria, Belgium, Bulgaria, Croatia, France, Germany, Greece, Ireland, Netherlands, Portugal, Romania, Spain |
| Wholesalers | Austria, Bulgaria, Croatia, Cyprus, Czechia, Estonia, Finland, Germany, Greece, Hungary, Iceland, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovakia, Slovenia |
| Feed mills | Belgium, Cyprus, Czechia, Italy, Malta, Norway |
| Pharmacies | Denmark, Italy, Sweden |
| Retailers | Italy |
| Veterinarians | Sweden |
Year-to-year percentage changes (%) in antimicrobial veterinary medicinal product sales (mg/PCU) in Poland and in Europe during 2011–2023 (10–21)
| Region | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poland | 123.6 | +7.0 | +14.4 | −7.7 | −1.1 | −6.9 | +27.6 | +2.7 | +10.0 | +1.5 | −6.6 | +11.7 | −23.0 |
| Rest of EU + EEA(mean) | 161.2 | −19.3 | +0.6 | −17.6 | +28.8 | −10.3 | −14.1 | −3.6 | −18.4 | +5.7 | −5.2 | −12.4 | +14.5 |
Antimicrobial veterinary medical products based on the ATCvet classification (5) grouped as products mandatory to report sales of and products voluntary to report sales of (5)
| Reporting | Antimicrobial substance group | ATCvet code |
|---|---|---|
| antidiarrhoeals, intestinal anti-inflammatory and anti-infective agents | QA07AA, QA07AB, QA07AX03, QA07AX04 | |
| gynaecological anti-infectives and antiseptics | QG01AA, QG01AE, QG01BA, QG01BE | |
| anti-infectives and antiseptics for intrauterine use | QG51AA, QG51AG | |
| Mandatory | antibacterials for systemic use | QJ01 |
| antibacterials for intramammary use | QJ51 | |
| antiprotozoals (with antibacterial effect) | QP51AG | |
| antimycobacterials for intramammary use | QJ54 | |
| antiprotozoals (other than QP51AG) | QP51 | |
| antifungals for topical use | QD01A | |
| antifungals for systemic use | QD01B | |
| antimycotics for systemic use | QJ02 | |
| antimycobacterials | QJ04 | |
| Voluntary | antivirals for systemic use | QJ05 |
| antibiotics and chemotherapeutics for dermatological use | QD06 | |
| other nasal preparations | QR01AX06, QR01AX08 | |
| ophthalmological anti-infectives | QS01AA, QS01AB, QS01AD, QS01AE, QS01CA, QS01C | |
| otological anti-infectives | QS02AA, QS02CA, QS03AA, QS03CA |
Decrease in antimicrobial veterinary medicinal product sales in EU and EEA countries between 2011 and 2023 (10, 21)
| 0–20.0% | 20.1–40.0% | 40.1–60.0% | 60.1–80.0% |
|---|---|---|---|
| Portugal (16.2%) | Austria (33.8%) | Czechia (49.2%) | Belgium (64.7%) |
| Sweden (14.5%) | Denmark (24.2%) | Cyprus (43.8%) | Germany (66.4%) |
| Estonia (39.7%) | Hungary (49.6%) | France (70.4%) | |
| Finland (24.4%) | Italy (51.4%) | Netherlands (65.3%) | |
| Iceland (28.3%) | Latvia (41.4%) | ||
| Ireland (28.0%) | Slovenia (47.2%) | ||
| Norway (40.0%) | Spain (53.4%) | ||
| United Kingdom (49.6%)* |
Main obligations of EU member states to reduce antimicrobial resistance imposed by Regulation (UE) 2019/6 (22)
| 1. | To only allow preventive use of antimicrobials in single animals and small groups following veterinary assessment |
| 2. | To restrict the metaphylactic use of antimicrobials |
| 3. | To ban specific antimicrobials from non-humans use (electively) |
| 4. | To collect data on the sales and use of antimicrobials |
| 5. | To prohibit the import of animals and animal products from third countries where antimicrobials have been used in a manner not compliant with EU rules |
Comparison of antimicrobial veterinary medicinal product sales indicators in Poland and selected EU countries (11)
| Country | 2011 sales (mg/PCU) | 2023 sales (mg/PCU) | 2011–2023 trend |
|---|---|---|---|
| Poland | 126.3 | 150.9 | Increasing |
| Belgium | 175.1 | 61.8 | Decreasing |
| Denmark | 42.1 | 31.9 | Decreasing |
| Germany | 211.5 | 71.1 | Decreasing |
| France | 133.6 | 39.5 | Decreasing |